Cancer Research Catalyst’s 10 Most-read Blog Posts of 2014
Check out the 10 blog posts from 2014 that attracted the most attention. They cover a lot of ground,...
Tag: FDA
Check out the 10 blog posts from 2014 that attracted the most attention. They cover a lot of ground,...
Just before the holidays, the U.S. Food and Drug Administration (FDA) had good news for the ovarian cancer research...
Last week, the U.S. Food and Drug Administration (FDA) announced the approval of a new vaccine—Gardasil 9—that prevents infection...
Earlier this month we witnessed another leap forward for immunotherapy when the FDA approved blinatumomab (Blincyto) for the treatment...
According to a new report in Cancer Epidemiology, Biomarkers & Prevention, the levels of several toxic substances are elevated...
Lung cancer awareness month started hot on the heels of two exciting pieces of news that highlight the promise...
In follow up to the AACR Cancer Progress Report 2014, AACR President Carlos L. Arteaga, MD, discusses our continuing...
The signature pink ribbons of Breast Cancer Awareness Month have become almost as much a part of October as...
Yesterday, the U.S. Food and Drug Administration (FDA) announced the highly anticipated approval of the cancer immunotherapeutic pembrolizumab (Keytruda)...